Nomura Initiates Sagility with Buy Rating, Targeting 47.4% Upside

Nomura has initiated coverage on Sagility with a Buy call and a target price of Rs 55, implying a 47.4% upside potential. The brokerage firm sees Sagility as a key beneficiary of the shift towards AI-led transformation in healthcare services. The company's deep domain expertise in healthcare strengthens its positioning in the evolving landscape. Engagement services, contributing 30% of revenue, are unlikely to face meaningful disruption. Nomura expects Sagility to deliver healthy growth, with revenue and EPS projected to clock CAGRs of 12% and 20%, respectively, over FY26-28F.